SRSapna Ramdin

Sapna Ramdin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sapna Ramdin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Nalini Govender

    Department of Basic Medical Sciences, Durban University of Technology, Durban, South Africa

    7 shared publications
  • Sooraj Baijnath

    Wits Integrated Molecular Physiology Research Initiative, Wits Health Consortium (PTY) Ltd, School of Physiology, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg, South Africa

    3 shared publications
  • Thajasvarie Naicker

    Optics and Imaging Centre, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

    3 shared publications
  • Thajasvarie Naicker

    Optics and Imaging Centre, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa

    2 shared publications
  • Blessing N Mkhwanazi

    Discipline of Dietetics and Nutrition, College of Agriculture, University of KwaZulu-Natal, Durban, South Africa

    1 shared publication
  • Charlotte Ramdass

    Department of Basic Medical Sciences, Faculty of Health Sciences, Durban University of Technology, Durban, 4001, South Africa, dut.ac.za

    1 shared publication

Latest Publications

  • Open Access

    Long term cardiometabolic outcomes in COVID positive patients

    by Lauren Chetty, Poovendhree Reddy, Sapna Ramdin, Nalini Govender

    In South Africa, approximately 4.5 million confirmed COVID-19 cases and 103,000 deaths have been noted. Symptoms range from being asymptomatic, mild respiratory issues to severe multi-organ failure and consequent death. Cardiometabolic risk factors, viz., type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), atherosclerosis, chronic kidney disease, hypertension, heart failure, and obesity, are flagged as the most prevalent comorbidities associated with the risk of severe COVID-19 and death. Many who have recovered from hospitalization continue to experience lingering symptoms known as long COVID, which have been linked to new-onset cardiometabolic disorders (CMD). This narrative review thus focusses on the clinical factors and the patient burden of diabetes mellitus and hypertension as two of the most commonly observed CMD, and aims to raise awareness regarding possible cardiometabolic complications. The findings expand the existing literature on the cardiometabolic effects of COVID-19, concentrating on outcomes observed more than three months after the acute phase of the illness.

  • Open Access

    COVID‐19 and Maternal–Neonatal Outcomes: A South African Retrospective Analysis

    by Charlotte Ramdass, Sapna Ramdin, Jagidesa Moodley, Stanley Chibuzor Onwubu, Randolph Green-Thompson, Nalini Govender

    Background: The maternal and neonatal outcomes of COVID‐19 in South Africa are under‐reported. This retrospective study therefore examined how the national COVID‐19 lockdown influenced access to antenatal care and its associated effects on maternal and neonatal outcomes at a South African tertiary hospital before and during the pandemic. Methods: The study was based on data obtained from the birth registry records of a tertiary hospital in KwaZulu‐Natal between pre‐COVID‐19 (March 2019–February 2020) and during the pandemic (March 2020–December 2020). No COVID‐19 diagnostic data was recorded and only singleton pregnancies were included. Unpaired t ‐tests and Pearson’s chi‐square tests were used to compare continuous and categorical variables, respectively. Binary logistic regression was done to evaluate associations between maternal features and labour complications. Results: A total of 8473 women accessed the hospital prior to ( n = 4866) and during the pandemic ( n = 3607). The majority of women attending the hospital during both time periods were aged between 19 and 35 years. Gestational age at delivery was significantly reduced during the pandemic (37.02 ± 4.10) versus the period prior (37.45 ± 3.74; p < 0.001). Additionally, during the pandemic, elective caesarean births increased significantly (10.31% vs. 6.33%), and the number of live births declined (3493 vs. 4705; p < 0.01). Rates of postpartum haemorrhage (1.95% vs. 0.56%), pre‐eclampsia (2.70% vs. 1.28%), sepsis (9.37% vs. 1.15%) and obstructed/prolonged childbirth (1.98% vs. 0.72%) increased significantly during the pandemic ( p < 0.01). Notably, during the pandemic, a 32‐fold increase in the risk of eclampsia (OR: 32.71; 95% CI: 4.31, 247.91; p = 0.001) was noted amongst primigravidae, with a higher risk of stillbirth in women aged between 19 and 35 (OR: 1.92; 95% CI: 1.14, 3.24; p < 0.05). Conclusion: We report a significant rise in maternal and neonatal complications during the pandemic. Our findings can be utilised to assess the risks, benefits and impact of various health interventions on affected individuals in similar disease settings, to improve maternal and neonatal health and decrease disease burden in LMICs.

  • Open Access

    Is renal dysfunction amplified in an arginine vasopressin induced rat model of preeclampsia?

    by Sapna Ramdin, Thajasvarie Naicker, Sooraj Baijnath, Nalini Govender

  • Open Access

    The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression

    by Sapna Ramdin, Sooraj Baijnath, Thajasvarie Naicker, Nalini Govender

    Purpose of Review: Preeclampsia (PE) is a leading global cause of maternal and fetal morbidity and mortality. The heterogeneity of this disorder contributes to its elusive etiology. Due to the ethical constraints surrounding human studies, animal models provide a suitable alternative for investigation into PE pathogenesis and novel therapeutic strategies. The purpose of this review is to compare and contrast the various rodent models used to study PE, in order to demonstrate their value in investigating and identifying different characteristics of this disorder.Recent Findings: Several approaches have been employed to create an appropriate animal model of PE, including surgical, genetic manipulation, and pharmacological methods in an attempt to mimic the maternal syndrome. Despite the absence of a model to completely model PE, these models have provided valuable information concerning various aspects of PE pathogenesis and novel therapeutic strategies and have led to the discovery of potential predictive markers of PE.Summary: Rodent and murine models have contributed significantly to the study of the pathology associated with specific aspects of the disorder. As a single fully encompassing animal model of PE remains absent, the use of a combination of models has potential value in understanding its etiology as well as in new treatment and management strategies.


  • Physiological characterization of an arginine vasopressin rat model of preeclampsia

    by Sapna Ramdin, Thajasvarie Naicker, Virushka Pillay, Sanil D. Singh, Sooraj Baijnath, Blessing N Mkhwanazi, Nalini Govender

    Rodent models have contributed greatly to our understanding of preeclampsia (PE) progression in humans, however to-date no model has been able to effectively replicate the clinical presentation of the disease. This study aimed to provide a thorough physiological characterization of the arginine vasopressin (AVP)-induced rat model of PE to determine its applicability in studying the pathophysiology of PE. Female Sprague Dawley rats (n = 24) were separated into four groups (n = 6 per group) viz., pregnant AVP, pregnant saline, non-pregnant AVP, and non-pregnant saline. All animals received a continuous dose of either AVP (150 ng/h) or saline via subcutaneous mini osmotic pumps for 18 days. Full physiological characterization of the model included measuring systolic and diastolic blood pressure, and collecting urine and blood samples for biochemical analysis. AVP infusion significantly increased blood pressure and urinary protein levels in the pregnant rats (p < 0.05). Biochemical markers measured, differed significantly in the AVP-treated vs the pregnant saline groups (p < 0.05). Placental and individual pup weight decreased significantly in the pregnant AVP vs pregnant saline group (p < 0.05). The physiological and hematological data confirm the usefulness of this rat model in the study of PE, since AVP-induced vasoconstriction increases peripheral resistance and successfully mimics the pathological changes associated with PE development in humans. Abbreviations: PE: preeclampsia; AVP: arginine vasopressin; ISSHP: International Society for the Study of Hypertension in Pregnancy; ACOG: American College of Obstetricians and Gynecologists; RUPP: reduced uterine perfusion pressure; sFlt-1: soluble fms-like tyrosine kinase; VEGF: vascular endothelial growth factor; PlGF: placental growth factor; AVP: arginine vasopressin; PAVP: pregnant AVP-treated; PS: pregnant saline; GD: gestational day; ALT: alanine transaminase; NAVP: non-pregnant AVP-treated; NS: non-pregnant saline; AST: aspartate aminotransferase; HDL: high-density lipoprotein; RBC: red blood cell; RAAS: renin-angiotensin aldosterone system; HELLP: hemolysis, elevated liver enzymes, low platelet.


  • Open Access

    Transforming growth factor-beta and liver injury in an arginine vasopressin-induced pregnant rat model

    by Nalini Govender, Sapna Ramdin, Rebecca Reddy, Thajasvarie Naicker

    Objective: Approximately 30% of preeclamptic pregnancies exhibit abnormal liver function tests. We assessed liver injury-associated enzyme levels and circulating transforming growth factor beta (TGF-β) levels in an arginine vasopressin (AVP)-induced pregnant Sprague-Dawley rat model.Methods: Pregnant and non-pregnant Sprague-Dawley rats (n=24) received AVP (150 ng/hr) subcutaneously via mini-osmotic pumps for 18 days. Blood pressure was measured, urine samples were collected, and all animals were euthanized via isoflurane. Blood was collected to measure circulating levels of TGF-β1-3 isomers and liver injury enzymes in pregnant AVP (PAVP), pregnant saline (PS), non-pregnant AVP (NAVP), and non-pregnant saline (NS) rats. Results: The PAVP group showed significantly higher systolic and diastolic blood pressure than both saline-treated groups. The weight per pup was significantly lower in the AVP-treated group than in the saline group (p<0.05). Circulating TGF-β1-3 isomer levels were significantly higher in the PAVP rats than in the NS rats. However, similar TGF-1 and TGF-3 levels were noted in the PS and PAVP rats, while TGF-2 levels were significantly higher in the PAVP rats. Circulating liver-type arginase-1 and 5'-nucleotidase levels were higher in the PAVP rats than in the saline group. Conclusion: This is the first study to demonstrate higher levels of TGF-β2, arginase, and 5'-nucleotidase activity in PAVP than in PS rats. AVP may cause vasoconstriction and increase peripheral resistance and blood pressure, thereby elevating TGF-β and inducing the preeclampsia-associated inflammatory response. Future studies should explore the mechanisms through which AVP dysregulates liver injury enzymes and TGF-β in pregnant rats.